FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to a compound representing bis(5-amino-1,4-dioxo-1,2,3,4-tetrahydrophthalazin-2-yl)zinc of formula (I) 
. Use of the compound of formula (I) (versions), a method for producing it, a based pharmaceutical composition, methods of treating skin diseases and gastritis are also presented.
EFFECT: invention enables producing the compound of formula (I), which provides relieving or eliminating negative consequences of skin and mucosal injuries.
63 cl, 27 dwg, 6 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION FOR TREATING BURNS AND WOUNDS BASED ON CYTOKINES AND GROWTH FACTORS, SECRETED BY MESENCHYMAL HUMAN CELLS, METHOD FOR THEREOF OBTAINING AND METHOD FOR TREATING BURNS AND WOUNDS | 2014 |
|
RU2574017C1 |
| METHOD OF RADIOINDUCED SKIN REACTIONS TREATMENT | 2022 |
|
RU2796754C1 |
| COMPOSITIONS CONTAINING BERBERINE OR ITS ANALOGUES FOR TREATING SKIN DISEASES RELATED TO ROSACEA OR BLUSH | 2010 |
|
RU2533458C2 |
| COMPOSITIONS CONTAINING BERBERINE OR ANALOGS THEREOF FOR TREATING ROSACEA OR RED FACE RELATED SKIN DISORDERS | 2014 |
|
RU2671492C2 |
| METHOD FOR PRODUCING AN ANTI-INFLAMMATORY AGENT BASED ON MAMMALIAN SPLEEN PEPTIDES, AGENT PRODUCED THEREBY AND APPLICATION THEREOF | 2021 |
|
RU2790158C1 |
| NEW MEDICINES FOR TOPICAL APPLICATION BASED ON SULPHATED HYALURONIC ACID AS STIMULATING OR INHIBITING AGENT OF CYTOKINE ACTIVITY | 2014 |
|
RU2673661C2 |
| NEW MEDICINES FOR TOPICAL APPLICATION BASED ON SULPHATED HYALURONIC ACID AS STIMULATING OR INHIBITING AGENTS OF CYTOKINE ACTIVITY | 2014 |
|
RU2673066C2 |
| COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
| PREPARATION FOR TREATING PERIODONTITIS | 2015 |
|
RU2604128C1 |
| NEW THERAPEUTIC AGENTS FOR LOCAL ADMINISTRATION BASED ON SULPHATED HYALURONIC ACID AS CYTOKINE ACTIVITY STIMULATORS OR INHIBITORS | 2010 |
|
RU2543354C2 |
